The Johns Hopkins CIR is looking for healthy volunteers to participate in an outpatient Zika investigational vaccine study. If you are between the ages of 18-50 you may be eligible to participate.
Phase I Evaluation of the Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D430-713 in Flavivirus-naïve Adults
No history of severe allergic reaction/ anaphylaxis
No history or lab evidence of previous ZIKV infection, dengue virus infection or flavivirus infection
No prior receipt of a flavivirus vaccine (licensed or experimental i.e Yellow fever)
Name of Clinical Site
301 Mason Lord Dr, Baltimore, MD, USA